Inhibition of amyloid formation of the Nucleoprotein of SARS-CoV-2
Authors | Einav Tayeb-Fligelman, Xinyi Cheng, Christen Tai, Jeannette T. Bowler, Sarah Griner, Michael R. Sawaya, Paul M. Seidler, Yi Xiao Jiang, Jiahui Lu, Gregory M. Rosenberg, Lukasz Salwinski, Romany Abskharon, Chih-Te Zee, Ke Hou, Yan Li, David Boyer, Kevin A. Murray, Genesis Falcon, Daniel H. Anderson, Duilio Cascio, Lorena Saelices, Robert Damoiseaux, Feng Guo, David Eisenberg |
---|---|
Details | bioRxiv. March 18, 2021 |
DOI | 10.1101/2021.03.05.434000 |
Topics | |
Keywords | |
Source | View on BioRxiv |
Nice–designing peptide inhibitors that target the zipper driving phase separation may be an option for therapeutic intervention.